Analytical White Papers
Free analytical and research White Papers on the topic of reimbursement, HTA and evidence requirements for medical devices and IVD tests in Europe
Recent news and posts
2025 Finnish NordDRG system came into force
On January 1, 2025, the annual update of the Finnish NordDRG system came into force. There are 1005 DRGs in the 2025 DRG system, compared to 981 DRGs in 2024. Among other changes, 54 new DRGs were introduced, and 30 DRGs were discontinued; these changes mostly relate to splitting already existing DRGs into uncomplicated, complicated, or very complicated cases. Some examples of new DRGs are provided below:
- 127M Heart failure or cardiogenic shock, very complicated;
- 705O Cardiac ultrasound, short treatment;
- 493C Endoscopic or laparoscopic cholecystectomy or gallbladder or bile duct surgery, complicated;
- 065N Balance disorder, uncomplicated;
- 349N Prostatic hyperplasia;
- 384B Pregnancy, uncomplicated;
- 248C Tendinitis, myositis or bursitis, complicated;
- 078C Pulmonary embolism, complicated;
- 082N Respiratory tumors, uncomplicated;
- 214N Spinal fusion, uncomplicated;
- 415M Operative treatment of infectious disease, very complicated.
See the full details in Finnish here (can be obtained per request).
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.